Stockscreener 앱 받기
9.54
0.10%
-0.01
전일 마감가:
$9.55
열려 있는:
$9.45
하루 거래량:
210.48K
Relative Volume:
0.28
시가총액:
$741.18M
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
19.08
EPS:
0.5
순현금흐름:
$60.93M
1주 성능:
-8.18%
1개월 성능:
-14.67%
6개월 성능:
-38.33%
1년 성능:
-60.17%
1일 변동 폭
$9.24
$9.56
1주일 범위
$9.17
$10.30
52주 변동 폭
$9.17
$24.36
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
9.51 | 744.30M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
110.19 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
341.96 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.01 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.16 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.26 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 업그레이드 | Argus | Hold → Buy |
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings is Now Oversold (IART) - Nasdaq
Integra LifeSciences Holdings Corp. Sees Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Integra LifeSciences Hits 52-Week Low at $10.36 Amidst Ongoing Struggles - Markets Mojo
Integra LifeSciences Opens Weak with 8.37% Gap Down Amid Market Concerns - Markets Mojo
Integra LifeSciences (NASDAQ:IART) Stock Price Down 7.7% Following Analyst Downgrade - MarketBeat
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Integra Lifesciences (IART) Analyst Rating Update: Wells Fargo L - GuruFocus
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - MarketBeat
Stocks making big moves this week: Flywire, First Advantage, Integra LifeSciences, Huron, and Montrose - Yahoo Finance
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2025 Earnings Call Transcript - Insider Monkey
Integra LifeSciences (NASDAQ:IART) Hits New 12-Month LowWhat's Next? - MarketBeat
Integra Lifesciences Holdings Corp (IART) Q4 2025 Earnings Call - GuruFocus
Integra LifeSciences Q4 Earnings Call Highlights - Yahoo Finance
Integra LifeSciences (IART) Stock Trades Down, Here Is Why - Finviz
Integra LifeSciences (NASDAQ:IART) Shares Gap DownWhat's Next? - MarketBeat
Earnings call transcript: Integra LifeSciences beats Q4 2025 EPS forecast - Investing.com
Integra LifeSciences (NASDAQ:IART) Surprises With Q4 CY2025 Sales - Finviz
Q4 2025 Integra Lifesciences Holdings Corp Earnings Call Transcript - GuruFocus
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Integra Lifesciences Holdings Q4 25 Earnings Conference Call At 8:30 AM ET - Nasdaq
Integra LifeSciences (IART) Anticipates Lower Q1 Revenue Than Ex - GuruFocus
INTEGRA LIFESCIENCES HLDGS ($IART) Releases Q4 2025 Earnings - Quiver Quantitative
Integra LifeSciences beats estimates but guides below consensus By Investing.com - Investing.com South Africa
Integra LifeSciences beats estimates but guides below consensus - Investing.com
Integra: Q4 Earnings Snapshot - marketscreener.com
Integra LifeSciences Reports Q4 Loss, Revenue Edges Down - Nasdaq
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results - TradingView
Integra LifeSciences Reports Q4 and Full Year 2025 Financial Results with Operational Progress and 2026 Financial Guidance - Quiver Quantitative
Goodwill hit drives 2025 loss at Integra LifeSciences (NASDAQ: IART) - Stock Titan
Integra takes $511M hit from tariffs, quality and supply issues - Stock Titan
Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect - Finviz
CEO Change: Can Integra LifeSciences Holdings Corporation deliver consistent dividendsJuly 2025 Price Swings & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know - Finviz
Is Integra LifeSciences Holdings Corporation a cyclical or defensive stockEarnings Beat & Reliable Breakout Forecasts - mfd.ru
1 Russell 2000 Stock to Target This Week and 2 That Underwhelm - Finviz
Integra LifeSciences (IART) to Release Earnings on Thursday - MarketBeat
Integra LifeSciences appoints new CTO and key executives By Investing.com - Investing.com South Africa
Integra LifeSciences Announces Key Executive Leadership Appointments - markets.businessinsider.com
Integra LifeSciences appoints new CTO and key executives - Investing.com
New tech and quality chiefs signal Integra’s next growth push - Stock Titan
VIX Spike: Is Integra LifeSciences Holdings Corporation stock a buy or sellJuly 2025 Drop Watch & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need To Know - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock influenced by commodity prices2025 Risk Factors & Accurate Technical Buy Alerts - mfd.ru
List of 16 Acquisitions by Integra LifeSciences (Feb 2026) - Tracxn
Integra LifeSciences stock faces scrutiny after Reuters report on TruDi system - Investing.com
Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 - Yahoo Finance
Integra LifeSciences Announces Fourth Quarter and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat
Investors in Integra LifeSciences Holdings (NASDAQ:IART) have unfortunately lost 84% over the last five years - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.41%
1.27%
자본화:
|
볼륨(24시간):